Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations

Details for Australian Patent Application No. 2007267550 (hide)

Owner The General Hospital Corporation

Inventors Oral, Ebru; Muratoglu, Orhun K.; Bodugoz-Senturk, Hatice

Agent Fisher Adams Kelly

Pub. Number AU-A-2007267550

PCT Pub. Number WO2007/140312

Priority 60/803,177 25.05.06 US

Filing date 25 May 2007

Wipo publication date 6 December 2007

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/140312 Priority application(s): WO2007/140312

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007267551-Well cleanup tool with real time condition feedback to the surface

2007267549-Method of riser deployment on a subsea wellhead